Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Arcadia Biosciences stock | $1.93

Learn how to easily invest in Arcadia Biosciences stock.

Arcadia Biosciences Inc is an agricultural inputs business based in the US. Arcadia Biosciences shares (RKDA) are listed on the NASDAQ and all prices are listed in US Dollars. Arcadia Biosciences employs 58 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Arcadia Biosciences

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RKDA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Arcadia Biosciences stock price (NASDAQ: RKDA)

Use our graph to track the performance of RKDA stocks over time.

Arcadia Biosciences shares at a glance

Information last updated 2021-10-23.
Latest market close$1.93
52-week range$1.99 - $6.40
50-day moving average $2.12
200-day moving average $2.48
Wall St. target price$5.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.04

Buy Arcadia Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Arcadia Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Arcadia Biosciences price performance over time

Historical closes compared with the close of $1.93 from 2021-10-25

1 week (2021-10-20) -8.53%
1 month (2021-09-27) -6.76%
3 months (2021-07-27) -16.45%
6 months (2021-04-27) -31.80%
1 year (2020-10-26) -41.52%
2 years (2019-10-25) -60.45%
3 years (2018-10-26) 4.25
5 years (2016-10-26) 12.18%

Arcadia Biosciences financials

Revenue TTM $9.7 million
Gross profit TTM $-814,000
Return on assets TTM -19.15%
Return on equity TTM -8.15%
Profit margin -7.16%
Book value $1.88
Market capitalisation $42.4 million

TTM: trailing 12 months

Shorting Arcadia Biosciences shares

There are currently 971,607 Arcadia Biosciences shares held short by investors – that's known as Arcadia Biosciences's "short interest". This figure is 30.3% down from 1.4 million last month.

There are a few different ways that this level of interest in shorting Arcadia Biosciences shares can be evaluated.

Arcadia Biosciences's "short interest ratio" (SIR)

Arcadia Biosciences's "short interest ratio" (SIR) is the quantity of Arcadia Biosciences shares currently shorted divided by the average quantity of Arcadia Biosciences shares traded daily (recently around 251711.65803109). Arcadia Biosciences's SIR currently stands at 3.86. In other words for every 100,000 Arcadia Biosciences shares traded daily on the market, roughly 3860 shares are currently held short.

However Arcadia Biosciences's short interest can also be evaluated against the total number of Arcadia Biosciences shares, or, against the total number of tradable Arcadia Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Arcadia Biosciences's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Arcadia Biosciences shares in existence, roughly 40 shares are currently held short) or 0.0439% of the tradable shares (for every 100,000 tradable Arcadia Biosciences shares, roughly 44 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Arcadia Biosciences.

Find out more about how you can short Arcadia Biosciences stock.

Arcadia Biosciences share dividends

We're not expecting Arcadia Biosciences to pay a dividend over the next 12 months.

Have Arcadia Biosciences's shares ever split?

Arcadia Biosciences's shares were split on a 1:20 basis on 23 January 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Arcadia Biosciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Arcadia Biosciences shares which in turn could have impacted Arcadia Biosciences's share price.

Arcadia Biosciences share price volatility

Over the last 12 months, Arcadia Biosciences's shares have ranged in value from as little as $1.99 up to $6.4. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Arcadia Biosciences's is -0.6074. This would suggest that Arcadia Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Arcadia Biosciences has bucked the trend.

Arcadia Biosciences overview

Arcadia Biosciences, Inc. engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; and nutritional oils, such as gamma linolenic acid oils. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Argentina, Canada, Africa, Austria, and India. The company was incorporated in 2002 and is headquartered in Davis, California.

Frequently asked questions

What percentage of Arcadia Biosciences is owned by insiders or institutions?
Currently 8.166% of Arcadia Biosciences shares are held by insiders and 11.271% by institutions.
How many people work for Arcadia Biosciences?
Latest data suggests 58 work at Arcadia Biosciences.
When does the fiscal year end for Arcadia Biosciences?
Arcadia Biosciences's fiscal year ends in December.
Where is Arcadia Biosciences based?
Arcadia Biosciences's address is: 202 Cousteau Place, Davis, CA, United States, 95618
What is Arcadia Biosciences's ISIN number?
Arcadia Biosciences's international securities identification number is: US0390142042
What is Arcadia Biosciences's CUSIP number?
Arcadia Biosciences's Committee on Uniform Securities Identification Procedures number is: 039014105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site